Thymopentin Dosage Guide: Research Protocols, Timing & Reconstitution

Standard Dosage Range

Research dosing range: 1–5 mg per dose (injection), 2–7 times per week

Educational reference only

These dosage ranges are derived from preclinical research and community protocols. No human clinical dose-ranging trials have established therapeutic doses for most research peptides. Always consult a qualified healthcare provider before starting any peptide protocol.

Dosage by Use Case

Primary Immunodeficiency

1–5 mg2–7× weekly

Duration

4–12 weeks

Subcutaneous or intramuscular injection. Often administered in cycles with breaks between. Doses may be adjusted based on immune marker responses.

Chronic Hepatitis B

1–3 mg2–3× weekly

Duration

12–24 weeks

Used as an adjunct to antiviral therapy. Subcutaneous or intramuscular administration. Monitor liver enzyme levels.

Rheumatoid Arthritis

2.5–5 mg2–3× weekly

Duration

8–16 weeks

Subcutaneous or intramuscular injection. Used to modulate immune response. Monitor disease activity scores.

HIV (Adjunct)

1–2 mg2–3× weekly

Duration

4–12 weeks

Used to enhance immune function. Subcutaneous or intramuscular administration. Should be used in conjunction with antiretroviral therapy. Monitor CD4 count.

Enhanced Vaccine Response (Immunocompromised/Elderly)

1 mg1× prior to vaccination

Duration

Single dose

Administered subcutaneously or intramuscularly prior to vaccination to improve immune response.

Timing & Frequency

Thymopentin can be administered at any time of day. Consistency in timing is recommended to maintain stable blood levels. Some protocols suggest administering in the morning.

Cycle Guidance

Cycling is common practice given the immunomodulatory effects. Typical cycles are 4–12 weeks on followed by 4–8 weeks off. Rationale is to prevent immune tolerance and optimize responsiveness. Monitoring immune markers may help guide cycling decisions.

Reconstitution Reference

Quick reference for reconstituting Thymopentin. For custom vial sizes and concentrations, use the Reconstitution Calculator.

Common Vial Size	Typically 1 mg or 5 mg per vial
BAC Water Volume	1 mL bacteriostatic water for 1 mg/mL or 5 mg/mL concentration
Concentration & Draw	At 1 mg/mL: 100 mcg = 0.1 mL (10 units on a 100-unit insulin syringe). At 5 mg/mL: 100 mcg = 0.02 mL (2 units on a 100-unit insulin syringe)
Storage	Refrigerate at 2–8°C after reconstitution. Keep lyophilized powder at room temperature or refrigerated.
Stability	Reconstituted solution stable up to 14 days refrigerated. Lyophilized powder stable 12-24 months per manufacturer specifications.

Use the Reconstitution Calculator → for precise injection volumes based on your exact vial size, water volume, and desired dose.

Frequently Asked Questions

What is the typical thymopentin dosage for rheumatoid arthritis?

Clinical studies often use 2.5–5 mg, administered 2–3 times weekly via subcutaneous or intramuscular injection, for a duration of 8–16 weeks. Monitor disease activity scores and adjust accordingly.

How long does it take to see effects from thymopentin?

Effects may be observed within a few weeks of consistent administration, but optimal results often require several months of continued treatment. Monitoring immune markers and clinical symptoms can help assess efficacy.

Can I take thymopentin orally?

Thymopentin is not effective orally due to rapid degradation in the digestive system. It must be administered via injection (subcutaneous or intramuscular) to ensure adequate bioavailability.

What is the half-life of thymopentin?

Thymopentin has a very short half-life of approximately 30 seconds. However, its immunomodulatory effects persist far longer due to its influence on immune cell signaling and differentiation.